Pages that link to "Q36476143"

The following pages link to Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment (Q36476143):

Displaying 30 items.

• Subcortical volumetric abnormalities in bipolar disorder (Q23747500) (← links)
• A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts (Q26741164) (← links)
• Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics (Q28081249) (← links)
• Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care (Q33835333) (← links)
• Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder (Q34111775) (← links)
• Potential mechanisms of action of lithium in bipolar disorder. Current understanding (Q34325612) (← links)
• Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders (Q34357070) (← links)
• Using lithium as a neuroprotective agent in patients with cancer (Q34465844) (← links)
• Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence (Q35006376) (← links)
• Using structural MRI to identify individuals at genetic risk for bipolar disorders: a 2-cohort, machine learning study (Q35976147) (← links)
• NCAN Cross-Disorder Risk Variant Is Associated With Limbic Gray Matter Deficits in Healthy Subjects and Major Depression (Q36059932) (← links)
• A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force (Q36217653) (← links)
• Differential effect of lithium on cell number in the hippocampus and prefrontal cortex in adult mice: a stereological study (Q36813181) (← links)
• Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder (Q36879689) (← links)
• CRMPs: critical molecules for neurite morphogenesis and neuropsychiatric diseases (Q38528533) (← links)
• Distinguishing medication-free subjects with unipolar disorder from subjects with bipolar disorder: state matters. (Q38792666) (← links)
• Therapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding (Q38957224) (← links)
• ZNF804A Genetic Variation Confers Risk to Bipolar Disorder (Q40984043) (← links)
• Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response (Q45789895) (← links)
• Disorder-specific volumetric brain difference in adolescent major depressive disorder and bipolar depression (Q46245218) (← links)
• Verbal memory impairment in new onset bipolar disorder: Relationship with frontal and medial temporal morphology (Q46628918) (← links)
• An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms (Q47294091) (← links)
• Increased hippocampal, thalamus and amygdala volume in long-term lithium-treated bipolar I disorder patients compared with unmedicated patients and healthy subjects (Q47960042) (← links)
• Hippocampal subfield volumes in short- and long-term lithium-treated patients with bipolar I disorder (Q48014141) (← links)
• Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia (Q48700368) (← links)
• First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia. (Q50556051) (← links)
• Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group (Q57166553) (← links)
• Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder (Q57832547) (← links)
• Larger right inferior frontal gyrus volume and surface area in participants at genetic risk for bipolar disorders (Q60622363) (← links)
• Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis (Q89165196) (← links)